Literature DB >> 19538430

Improving platelet supply chains through collaborations between blood centers and transfusion services.

Magali J Fontaine1, Yenho T Chung, William M Rogers, Harry D Sussmann, Peter Quach, Susan A Galel, Lawrence T Goodnough, Feryal Erhun.   

Abstract

BACKGROUND: Blood centers and hospital transfusion services are challenged with maintaining an adequate platelet (PLT) inventory to minimize the number of outdated units without risking a major shortage. A novel approach to inventory management was established at our institution through a collaboration between the Stanford University Medical Center (SUMC) Transfusion Service, the Stanford Blood Center (SBC), and the Department of Management Science and Engineering. STUDY DESIGN AND METHODS: An analysis of the supply chain performance between SBC and SUMC Transfusion Service was performed. First, the interaction between processes, such as blood collection, rotation, and inventory management, was studied. Second, changes were implemented based on the recommendations from the analysis team. Finally, a postanalysis was performed reflecting on the improvement of the operations between SUMC and SBC.
RESULTS: A comprehensive data analysis of the PLT supply chain allowed the identification of three series of improvements to be implemented: 1) on SBC's PLT collection, 2) on SBC's rotation process, and 3) on the PLT inventory management policy at SUMC. A postimplementation analysis showed a reduction in the overall PLT outdate rate from 19% in the first quarter of 2006, down to 9% in the third quarter of 2008.
CONCLUSION: A multidisciplinary effort among SUMC Transfusion Service, SBC, and experts in supply chain management resulted in a process improvement, which reduced the rate of PLT outdate at both SBC and SUMC Transfusion Service down to 9%, with a significant cost reduction of more than half a million dollars per year.

Entities:  

Mesh:

Year:  2009        PMID: 19538430     DOI: 10.1111/j.1537-2995.2009.02236.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease.

Authors:  Deirdre Mladsi; Christine Barnett; Kavita Aggarwal; Michael Vredenburg; Douglas Dieterich; Ray Kim
Journal:  Clinicoecon Outcomes Res       Date:  2020-09-14

2.  Peripherally inserted central catheter placement in cancer patients with profound thrombocytopaenia: a prospective analysis.

Authors:  Julien Potet; Alphonse Thome; Emmanuel Curis; François-Xavier Arnaud; Gabrielle Weber-Donat; Laura Valbousquet; Evelyne Peroux; Eric Flor; Christophe Dody; Johanna Konopacki; Jean Valère Malfuson; Cecile Cartry; Marion Lahutte; Thierry de Revel; Jacques Baccialone; Christophe A Teriitehau
Journal:  Eur Radiol       Date:  2013-02-26       Impact factor: 5.315

3.  Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.

Authors:  Nigel Armstrong; Nasuh Büyükkaramikli; Hannah Penton; Rob Riemsma; Pim Wetzelaer; Vanesa Huertas Carrera; Stephanie Swift; Thea Drachen; Heike Raatz; Steve Ryder; Dhwani Shah; Titas Buksnys; Gill Worthy; Steven Duffy; Maiwenn Al; Jos Kleijnen
Journal:  Health Technol Assess       Date:  2020-10       Impact factor: 4.014

4.  Cost implications of implementation of pathogen-inactivated platelets.

Authors:  Jeffrey McCullough; Dennis Goldfinger; Jed Gorlin; William J Riley; Harpreet Sandhu; Christopher Stowell; Dawn Ward; Mary Clay; Shelley Pulkrabek; Vera Chrebtow; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-05-18       Impact factor: 3.157

5.  The supply chain of blood products in the wake of the COVID-19 pandemic: Appointment scheduling and other restrictions.

Authors:  Nabil Kenan; Ali Diabat
Journal:  Transp Res E Logist Transp Rev       Date:  2022-01-29       Impact factor: 6.875

6.  Toward a patient-based paradigm for blood transfusion.

Authors:  Albert Farrugia; Eleftherios Vamvakas
Journal:  J Blood Med       Date:  2014-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.